| Literature DB >> 35698021 |
Sacha Agrawal1, Samuel Law2, Matthew Levy2, Laura Williams3, Maria Mylopoulos4.
Abstract
Entities:
Year: 2022 PMID: 35698021 PMCID: PMC9191753 DOI: 10.1007/s40596-022-01668-3
Source DB: PubMed Journal: Acad Psychiatry ISSN: 1042-9670
Learning objectives
| Week | Objective 1 | Objective 2 | Objective 3 |
|---|---|---|---|
| 1 | Early intervention | Metabolic side effects | Recovery-oriented health services |
| 2 | Injectable antipsychotics | Community treatment orders | Extra-pyramidal side effects |
| 3 | Violence | Clozapine | LGBTQ2S considerations |
| 4 | Trauma | Ultra-treatment resistance | CBT for psychosis |
| 5 | Negative and cognitive symptoms | Psychosocial rehabilitation | Schizophrenia neuroscience |
| 6 | Cannabis and schizophrenia | Tardive dyskinesia | Anti-Black racism |
| 7 | Poverty and homelessness | Indigenous health considerations | Suicide |
| 8 | Intellectual disability and psychosis | Tobacco | Migration and minority status |
| 9 and 10 | Bipolar disorder—pharmacotherapy | Bipolar disorder—psychosocial interventions | Measurement-based care |
Fig. 1Excerpt from a clinical case showing: a inclusion of clinical features that disconfirm negative stereotypes, b integration and foregrounding of the lived experience of racism, c creation of realistic clinical ambiguity, d use of questions that drive mechanistic learning, and e use of questions that introduce meaningful variation